Literature DB >> 970998

Raised serum immunoglobulin E in Wegener's granulomatosis.

D L Conn, G J Gleich, R A DeRemee, T J McDonald.   

Abstract

Five patients with Wegner's granulomatosis were found to have significantly raised serum immunoglobulin E (IgE) levels. The rise in IgE was not related to the extent of clinical involvement, was not part of a generalized serum immunoglobulin rise, and was not associated with eosinophilia. Raised serum IgE may be a clue to the pathogenesis of this disease.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 970998      PMCID： PMC1007400          DOI： 10.1136/ard.35.4.377

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  12 in total

1.  Suppressor T cells as regulators of lymphocyte functions.

Authors:  C W Pierce; D L Peavy; T Tadakuma
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

Review 2.  The clinical significance of IgE.

Authors:  S G Johansson; H H Bennich; T Berg
Journal:  Prog Clin Immunol       Date:  1972

3.  Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E.

Authors:  R Patterson; J N Fink; J J Pruzansky; C Reed; M Roberts; R Slavin; C R Zeiss
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

4.  Measurement of IgE in normal and allergic serum by radioimmunoassay.

Authors:  G J Gleich; A K Averbeck; H A Swedlund
Journal:  J Lab Clin Med       Date:  1971-04

5.  Wegener's granulomatosis: studies in eighteen patients and a review of the literature.

Authors:  A S Fauci; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1973-11       Impact factor: 1.889

6.  Automated quantitative immunochemical analysis of human immunoglobulins.

Authors:  H Markowitz; A R Tschida
Journal:  Clin Chem       Date:  1972-11       Impact factor: 8.327

7.  IgE levels in atopic dermatitis.

Authors:  S P Stone; S A Muller; G J Gleich
Journal:  Arch Dermatol       Date:  1973-12

8.  Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis.

Authors:  A S Fauci; S M Wolff; J S Johnson
Journal:  N Engl J Med       Date:  1971-12-30       Impact factor: 91.245

9.  Lack of suppression of certain immunoglobulin-producing lymphocytes in T-lymphocyte deficiency.

Authors:  A S Goldman; R A Lord; E Dupree; R M Goldblum; C W Smith; E V Dahl
Journal:  Clin Immunol Immunopathol       Date:  1974-09

10.  Evaluation of IgE tests in an allergy practice.

Authors:  L L Henderson; H A Swedlund; R G Van Dellen; J P Marcoux; H M Carryer; G A Peters; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1971-12       Impact factor: 10.793
View more
  5 in total

Review 1.  Vasculitis and granulomatosis of the respiratory tract.

Authors:  C W Edwards
Journal:  Thorax       Date:  1982-02       Impact factor: 9.139

2.  [The spectrum of histocompatibility antigens (HLA) in Wegener's granulomatosis (author's transl)].

Authors:  A Beigel; H Lehmann; E Westphal
Journal:  Arch Otorhinolaryngol       Date:  1981

3.  Association of Wegener's granulomatosis with HLA antigens and other genetic markers.

Authors:  S S Papiha; G E Murty; A Ad'Hia; B T Mains; M Venning
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 4.  AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  D Ferastraoaru; H J Bax; C Bergmann; M Capron; M Castells; D Dombrowicz; E Fiebiger; H J Gould; K Hartmann; U Jappe; G Jordakieva; D H Josephs; F Levi-Schaffer; V Mahler; A Poli; D Rosenstreich; F Roth-Walter; M Shamji; E H Steveling-Klein; M C Turner; E Untersmayr; S N Karagiannis; E Jensen-Jarolim
Journal:  Clin Transl Allergy       Date:  2020-07-17       Impact factor: 5.871

Review 5.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.